Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.
cognition
education
marijuana
preillness
schizophrenia
sociability
Journal
Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760
Informations de publication
Date de publication:
10 04 2020
10 04 2020
Historique:
pubmed:
31
7
2019
medline:
15
5
2021
entrez:
31
7
2019
Statut:
ppublish
Résumé
Psychotic patients with a lifetime history of cannabis use generally show better cognitive functioning than other psychotic patients. Some authors suggest that cannabis-using patients may have been less cognitively impaired and less socially withdrawn in their premorbid life. Using a dataset comprising 948 patients with first-episode psychosis (FEP) and 1313 population controls across 6 countries, we examined the extent to which IQ and both early academic (Academic Factor [AF]) and social adjustment (Social Factor [SF]) are related to the lifetime frequency of cannabis use in both patients and controls. We expected a higher IQ and a better premorbid social adjustment in psychotic patients who had ever used cannabis compared to patients without any history of use. We did not expect such differences in controls. In both patients and controls, IQ was 3 points higher among occasional-users than in never-users (mean difference [Mdiff] = 2.9, 95% CI = [1.2, 4.7]). Both cases and control daily-users had lower AF compared to occasional (Mdiff = -0.3, 95% CI = [-0.5; -0.2]) and never-users (Mdiff = -0.4, 95% CI = [-0.6; -0.2]). Finally, patient occasional (Mdiff = 0.3, 95% CI = [0.1; 0.5]) and daily-users (Mdiff = 0.4, 95% CI = [0.2; 0.6]) had better SF than their never-using counterparts. This difference was not present in controls (Fgroup*frequency(2, 2205) = 4.995, P = .007). Our findings suggest that the better premorbid social functioning of FEP with a history of cannabis use may have contributed to their likelihood to begin using cannabis, exposing them to its reported risk-increasing effects for Psychotic Disorders.
Identifiants
pubmed: 31361020
pii: 5540368
doi: 10.1093/schbul/sbz077
pmc: PMC7147569
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
517-529Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008436/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101272/Z/13/Z
Pays : United Kingdom
Investigateurs
Silvia Amoretti
(S)
Grégoire Baudin
(G)
Stephanie Beards
(S)
Domenico Berardi
(D)
Chiara Bonetto
(C)
Bibiana Cabrera
(B)
Angel Carracedo
(A)
Thomas Charpeaud
(T)
Javier Costas
(J)
Doriana Cristofalo
(D)
Pedro Cuadrado
(P)
Aziz Ferchiou
(A)
Nathalie Franke
(N)
Flora Frijda
(F)
Enrique García Bernardo
(E)
Paz Garcia-Portilla
(P)
Javier González Peñas
(J)
Emiliano González
(E)
Kathryn Hubbard
(K)
Stéphane Jamain
(S)
Estela Jiménez-López
(E)
Antonio Lasalvia
(A)
Marion Leboyer
(M)
Gonzalo López Montoya
(G)
Esther Lorente-Rovira
(E)
Covadonga M Díaz-Caneja
(C)
Camila Marcelino Loureiro
(C)
Giovanna Marrazzo
(G)
Covadonga Martínez
(C)
Mario Matteis
(M)
Elles Messchaart
(E)
Ma Dolores Moltó
(MD)
Carmen Moreno
(C)
Nacher Juan
(N)
Ma Soledad Olmeda
(MS)
Mara Parellada
(M)
Baptiste Pignon
(B)
Marta Rapado
(M)
Jean-Romain Richard
(JR)
José Juan Rodríguez Solano
(JJ)
Paulo Rossi Menezes
(P)
Mirella Ruggeri
(M)
Pilar A Sáiz
(PA)
Teresa Sánchez-Gutierrez
(T)
Emilio Sánchez
(E)
Crocettarachele Sartorio
(C)
Franck Schürhoff
(F)
Fabio Seminerio
(F)
Rosana Shuhama
(R)
Simona A Stilo
(SA)
Fabian Termorshuizen
(F)
Sarah Tosato
(S)
Anne-Marie Tronche
(AM)
Daniella van Dam
(D)
Elsje van der Ven
(E)
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
J Child Adolesc Subst Abuse. 2010 Apr 1;19(2):135-157
pubmed: 20485542
Arch Gen Psychiatry. 2003 Jun;60(6):565-71
pubmed: 12796219
J Int Neuropsychol Soc. 2003 Jul;9(5):679-89
pubmed: 12901774
Br J Psychiatry. 2009 Dec;195(6):488-91
pubmed: 19949195
Soc Psychiatry Psychiatr Epidemiol. 2002 Jul;37(7):329-35
pubmed: 12111025
PLoS One. 2016 Aug 11;11(8):e0160949
pubmed: 27513670
Psychiatry Res. 2014 Mar 30;215(3):528-32
pubmed: 24461684
Psychol Med. 1998 Nov;28(6):1411-9
pubmed: 9854282
Am J Psychiatry. 2010 Jan;167(1):78-85
pubmed: 19952077
Schizophr Res. 2003 Oct 1;63(3):297-9
pubmed: 12957709
Arch Gen Psychiatry. 1999 Aug;56(8):749-54
pubmed: 10435610
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
Schizophr Res. 2011 May;128(1-3):111-6
pubmed: 21420282
Schizophr Res. 2013 May;146(1-3):132-7
pubmed: 23490759
J Abnorm Child Psychol. 1996 Aug;24(4):499-512
pubmed: 8886945
Schizophr Bull. 2013 Nov;39(6):1288-95
pubmed: 23091267
J Neurosci. 2007 Apr 11;27(15):3998-4003
pubmed: 17428975
Schizophr Bull. 2008 Sep;34(5):801-5
pubmed: 18586693
Schizophr Res. 2015 Oct;168(1-2):231-7
pubmed: 26260081
Schizophr Res. 2013 Jan;143(1):84-9
pubmed: 23178107
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
pubmed: 1883262
Schizophr Res. 2013 Oct;150(1):129-35
pubmed: 23958486
Psychopharmacology (Berl). 2016 Mar;233(5):809-21
pubmed: 26621349
Lancet. 2007 Jul 28;370(9584):319-28
pubmed: 17662880
Schizophr Bull. 1992;18(2):319-32
pubmed: 1377834
Psychiatry. 1992 Nov;55(4):314-35
pubmed: 1470672
Psychol Med. 1996 Jul;26(4):775-83
pubmed: 8817712
Schizophr Res. 2007 Feb;90(1-3):255-7
pubmed: 17178214
Epidemiology. 2009 Jan;20(1):14-7
pubmed: 19234397
J Abnorm Psychol. 1995 Nov;104(4):558-66
pubmed: 8530757
Schizophr Res. 2015 Oct;168(1-2):245-51
pubmed: 26235754
Psychol Med. 2019 Jun;49(8):1378-1391
pubmed: 30282569
Schizophr Res. 2011 Dec;133(1-3):133-42
pubmed: 21999904
J Nerv Ment Dis. 2010 Feb;198(2):159-62
pubmed: 20145493
Schizophr Res Cogn. 2016 Oct 10;6:15-21
pubmed: 28740820
Front Hum Neurosci. 2009 Nov 24;3:53
pubmed: 19956405
Psychiatry Res. 2017 Apr;250:92-98
pubmed: 28152399
Exp Clin Psychopharmacol. 2012 Oct;20(5):420-429
pubmed: 22731735
Schizophr Bull. 2011 May;37(3):631-9
pubmed: 19915168
Lancet Psychiatry. 2015 May;2(5):382
pubmed: 26360275
BMJ Open. 2017 Feb 22;7(2):e012989
pubmed: 28228447
Schizophr Res. 2010 Dec;124(1-3):142-51
pubmed: 20826079
Schizophr Res. 2008 Mar;100(1-3):242-51
pubmed: 17614260
Br J Psychiatry. 2001 May;178:420-6
pubmed: 11331557
Schizophr Bull. 1982;8(3):470-84
pubmed: 7134891
Addiction. 2003 Dec;98(12):1681-92
pubmed: 14651500
Drug Alcohol Depend. 1982 Aug;9(4):285-303
pubmed: 6982159
Evid Based Ment Health. 2008 Feb;11(1):28
pubmed: 18223063
Aust N Z J Psychiatry. 2016 Mar;50(3):208-19
pubmed: 26286531
Addiction. 2002 Jul;97(7):833-44
pubmed: 12133122
Neuropharmacology. 2017 Sep 15;124:89-104
pubmed: 28634109
Am J Psychiatry. 2002 Dec;159(12):2021-6
pubmed: 12450951
Eur J Public Health. 2010 Apr;20(2):157-63
pubmed: 19805506
Cogn Neuropsychiatry. 2013;18(6):574-93
pubmed: 23167265
JAMA Psychiatry. 2018 Jan 1;75(1):36-46
pubmed: 29214289
PLoS One. 2015 Apr 07;10(4):e0122404
pubmed: 25849623
Psychopathology. 2015;48(2):120-6
pubmed: 25720419
Stat Med. 2000 May 15;19(9):1141-64
pubmed: 10797513
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4251-4
pubmed: 23319626
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64
pubmed: 22927402
Schizophr Bull. 2020 Feb 26;46(2):336-344
pubmed: 31206164
Lancet. 2014 May 10;383(9929):1677-1687
pubmed: 24315522
CMAJ. 2002 Apr 2;166(7):887-91
pubmed: 11949984
Am J Psychiatry. 2018 Nov 1;175(11):1121-1128
pubmed: 30138044
Addict Biol. 2012 Nov;17(6):981-90
pubmed: 21812871
BMC Med. 2004 Apr 28;2:13
pubmed: 15115547
Schizophr Res. 2009 Jul;112(1-3):136-42
pubmed: 19410430
J Psychiatry Neurosci. 2002 Mar;27(2):92-101
pubmed: 11944510
Schizophr Res. 2011 Mar;126(1-3):71-6
pubmed: 21036542
Schizophr Res. 2015 May;164(1-3):65-73
pubmed: 25819935
Schizophr Res. 2012 Jul;138(2-3):183-7
pubmed: 22475382
Drug Alcohol Depend. 1980 Apr;5(4):273-304
pubmed: 7371495
Schizophr Bull. 2012 Mar;38(2):316-30
pubmed: 20660494
Schizophr Bull. 2008 Sep;34(5):981-3
pubmed: 18032397
Schizophr Res. 2012 Mar;135(1-3):134-8
pubmed: 22130110
Addiction. 1997 Mar;92(3):279-96
pubmed: 9219390
Indian J Psychiatry. 1999 Oct;41(4):350-7
pubmed: 21430810
Schizophr Bull. 2012 Jun;38(4):873-80
pubmed: 21389110
Biol Psychiatry. 2016 Apr 1;79(7):549-56
pubmed: 26386480
Nat Rev Genet. 2018 Mar;19(3):148-159
pubmed: 29335645
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
Soc Psychiatry Psychiatr Epidemiol. 2004 Jan;39(1):69-72
pubmed: 15022049
Psychopharmacology (Berl). 2009 Jul;205(1):45-52
pubmed: 19326102
Br Med J (Clin Res Ed). 1987 Sep 19;295(6600):681-2
pubmed: 3117295
J Psychopharmacol. 2018 Aug;32(8):825-849
pubmed: 29591635
Ann Epidemiol. 2012 Sep;22(9):654-7
pubmed: 22776465
Schizophr Res. 2010 Jul;120(1-3):101-7
pubmed: 20471224
Schizophr Res. 2006 Dec;88(1-3):55-62
pubmed: 16971092
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:79-85
pubmed: 23871750
Drug Alcohol Depend. 2012 Sep 1;125(1-2):164-8
pubmed: 22520690
Curr Opin Psychiatry. 2007 May;20(3):228-34
pubmed: 17415074
J Psychiatr Res. 2018 Apr;99:22-32
pubmed: 29407284
Schizophr Res. 2005 Jun 1;75(1):135-7
pubmed: 15820332